Related Experiment Video
Updated: Jan 28, 2026

Microfluidic Device for the Separation of Non-Metastatic MCF-7 and Non-Tumor MCF-10A Breast Cancer Cells Using AC Dielectrophoresis
Published on: August 11, 2022
Expression of Snail and E-cadherin in Drug-resistant MCF-7/ADM Breast Cancer Cell Strains
Fenglin Cai1, Hualin Xiao2, Yuting Sun2
1Department of General Surgery, The Affiliated Cancer Hospital of Nanjing Medical University and Jiangsu Cancer Hospital, and Jiangsu Institute of Cancer Research, 210009, China.
Objective:
To investigate the expression of zinc finger transcription factors-Snail and E-cadherin in adriamycin-resistant human breast cancer MCF-7/ADM cells and non-resistant MCF-7 cells.
Study Design:
An experimental study.
Place And Duration Of Study:
The Affiliated Cancer Hospital of Nanjing Medical University and Jiangsu Cancer Hospital, and Jiangsu Institute of Cancer Research, China, from April 2017 to March 2018.
Methodology:
Real-time quantitative PCR technology was used to detect the expression levels of Snail mRNA and E-cadherin mRNA in normal breast cells, adriamycin-resistant human breast cancer MCF-7/ADM cells and non-resistant MCF-7 cells. Western blot was used to detect the expression levels of proteins of Snail and E-cadherin in normal breast cells, adriamycin-resistant human breast cancer MCF-7/ADM cells and non-resistant MCF-7 cells.
Results:
The expression of Snail mRNA and protein in adriamycin-resistant human breast cancer MCF-7/ADM cells was significantly higher than that in normal breast cells (p<0.001) and non-resistant MCF-7 cells (p<0.001). The expression of E-cadherin mRNA and protein in adriamycin-resistant human breast cancer MCF-7/ADM cells was significantly lower than that in normal breast cells (p<0.001) and non-resistant MCF-7 cells (p<0.001).
Conclusion:
Adriamycin-resistant human breast cancer MCF-7/ADM cell strains had high expression of Snail and low expression of E-cadherin. This points out to a new research direction for the targeted therapy of drug-resistant breast cancer cells, and provides clinical guidance for breast cancer therapy and prognosis evaluation.
Insights
Drug-resistant breast cancer cells show increased Snail and decreased E-cadherin expression. This finding offers new avenues for targeted therapy in adriamycin-resistant breast cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Breast cancer remains a significant global health challenge.
- Adriamycin resistance is a major obstacle in effective breast cancer treatment.
- Understanding the molecular mechanisms of drug resistance is crucial for developing new therapies.
Purpose of the Study:
- To investigate the differential expression of Snail and E-cadherin in adriamycin-resistant (MCF-7/ADM) versus non-resistant (MCF-7) human breast cancer cells.
- To analyze the role of these key transcription factors in the development of adriamycin resistance.
Main Methods:
- Utilized real-time quantitative PCR to assess mRNA expression levels of Snail and E-cadherin.
- Employed Western blot analysis to determine the protein expression levels of Snail and E-cadherin.
- Compared expression patterns in normal breast cells, MCF-7/ADM cells, and MCF-7 cells.
Main Results:
- Significantly higher expression of Snail mRNA and protein was observed in MCF-7/ADM cells compared to normal and MCF-7 cells (p<0.001).
- Significantly lower expression of E-cadherin mRNA and protein was detected in MCF-7/ADM cells compared to normal and MCF-7 cells (p<0.001).
Conclusions:
- Adriamycin-resistant human breast cancer MCF-7/ADM cells exhibit elevated Snail and diminished E-cadherin expression.
- These findings suggest Snail and E-cadherin as potential therapeutic targets for overcoming adriamycin resistance in breast cancer.
- Provides valuable insights for clinical breast cancer therapy and prognosis evaluation.
Related Concept Videos
Structure of Cadherins
Treatment Resistant Cancers
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Cell Specific Gene Expression
Resistivity
Resistance

